Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end. En savoir plus sur Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end.
Percutaneous mechanical atherothrombectomy using the Rotarex <sup>®</sup>S device in peripheral artery in-stent restenosis or occlusion: a French retrospective multicenter study on 128 patients. En savoir plus sur Percutaneous mechanical atherothrombectomy using the Rotarex ®S device in peripheral artery in-stent restenosis or occlusion: a French retrospective multicenter study on 128 patients.
Causes of impaired biventricular pacing in cardiac resynchronization devices with left ventricular sensing. En savoir plus sur Causes of impaired biventricular pacing in cardiac resynchronization devices with left ventricular sensing.
Body Mass Index as a Major Risk Factor for Severe Breast Cancer-Related Lymphedema. En savoir plus sur Body Mass Index as a Major Risk Factor for Severe Breast Cancer-Related Lymphedema.
Electrogram morphology discriminators in implantable cardioverter defibrillators: A comparative evaluation. En savoir plus sur Electrogram morphology discriminators in implantable cardioverter defibrillators: A comparative evaluation.
Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study. En savoir plus sur Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study.
Idiopathic Ventricular Fibrillation: Role of Purkinje System and Microstructural Myocardial Abnormalities. En savoir plus sur Idiopathic Ventricular Fibrillation: Role of Purkinje System and Microstructural Myocardial Abnormalities.
Implantable cardiac defibrillator leads dysfunction after LVAD implantation. En savoir plus sur Implantable cardiac defibrillator leads dysfunction after LVAD implantation.
Evaluation of the QT interval in patients with drug-induced QT prolongation and torsades de pointes. En savoir plus sur Evaluation of the QT interval in patients with drug-induced QT prolongation and torsades de pointes.
Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks. En savoir plus sur Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks.